Form 8-K - Current report:
SEC Accession No. 0001193125-26-339131
Filing Date
2026-08-07
Accepted
2026-08-07 07:05:30
Documents
12
Period of Report
2026-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K cgc-20260807.htm   iXBRL 8-K 53648
2 EX-99.1 cgc-ex99_1.htm EX-99.1 633270
3 GRAPHIC img62664582_0.jpg GRAPHIC 171071
4 GRAPHIC img62664582_1.gif GRAPHIC 18462
  Complete submission text file 0001193125-26-339131.txt   1098128

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cgc-20260807.xsd EX-101.SCH 30684
15 EXTRACTED XBRL INSTANCE DOCUMENT cgc-20260807_htm.xml XML 4505
Mailing Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8
Business Address 1 HERSHEY DRIVE SMITH FALLS A6 K7A0A8 855-558-9333
Canopy Growth Corp (Filer) CIK: 0001737927 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38496 | Film No.: 261251384
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)